No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02512335 | ACCEL-HYOSCINE | ACCEL PHARMA INC | Tablet | HYOSCINE BUTYLBROMIDE 10 MG | Marketed |
| 00363839 | BUSCOPAN | SANOFI CONSUMER HEALTH INC | Solution | HYOSCINE BUTYLBROMIDE 20 MG | Marketed |
| 02282089 | BUSCOPAN INJECTION FOR HORSES | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Solution | HYOSCINE BUTYLBROMIDE 20 MG | Marketed |
| 02229868 | HYOSCINE BUTYLBROMIDE INJECTION | SANDOZ CANADA INCORPORATED | Solution | HYOSCINE BUTYLBROMIDE 20 MG | Marketed |
| 02560984 | HYOSCINE BUTYLBROMIDE INJECTION | AS KALCEKS | Solution | HYOSCINE BUTYLBROMIDE 20 MG | Approved |
| 02508419 | HYOSCINE BUTYLBROMIDE INJECTION BP | OMEGA LABORATORIES LIMITED | Solution | HYOSCINE BUTYLBROMIDE 20 MG | Marketed |
| 00363820 | BUSCOPAN SUP 10MG | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Suppository | HYOSCINE BUTYLBROMIDE 10 MG | Cancelled Post Market |
7 valid EDQM Certificates of Suitability from 7 holders.